CDC20 and prostate cancer: Overexpression of CDC20 was observed in a variety of human tumors including pancreatic cancer, breast cancer, prostate cancer, lung cancer, colorectal cancer, hepatocellular carcinoma, glioblastoma, gastric cancer, and other types of human cancer (24–27).